← Back to Clinical Trials
Recruiting NCT07323498

NCT07323498 Enhancing Generalization of Virtual Reality Exposure for Public Speaking Anxiety

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07323498
Status Recruiting
Phase
Sponsor Philipps University Marburg
Condition Public Speaking Anxiety
Study Type INTERVENTIONAL
Enrollment 48 participants
Start Date 2025-11-26
Primary Completion 2026-11

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 70 Years
Study Type INTERVENTIONAL
Interventions
VR ExposureStandard Mental RehearsalMental Rehearsal With Extinction Memory Updating

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 48 participants in total. It began in 2025-11-26 with a primary completion date of 2026-11.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This randomized controlled trial examines whether imagery-based extinction memory updating following a standardized virtual reality (VR) exposure session improves the generalization of exposure effects to novel public speaking contexts. Individuals with elevated public speaking anxiety will complete a single-session VR speech exposure. Participants are randomized to (a) standard mental rehearsal of the exposure experience or (b) mental rehearsal plus guided imagery that updates the extinction memory with novel, non-exposed contexts. Generalization is assessed 7-14 days later using a multi-context behavioral approach test (BAT) in vivo and in VR.

Eligibility Criteria

Inclusion Criteria: * speech anxiety scale score of ≥ 18 on the Personal Report of Communication Apprehension, Public Speaking Subscale (PRCA-PS) * Self-report of 18 - 70 years of age Exclusion Criteria: \-

Contact & Investigator

Central Contact

Christoph Benke, Ph.D.

✉ christoph.benke@uni-marburg.de

📞 +49 6421 28-24091

Principal Investigator

Christoph Benke, Ph.D.

PRINCIPAL INVESTIGATOR

Philiips-University of Marburg

Frequently Asked Questions

Who can join the NCT07323498 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Public Speaking Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07323498 currently recruiting?

Yes, NCT07323498 is actively recruiting participants. Contact the research team at christoph.benke@uni-marburg.de for enrollment information.

Where is the NCT07323498 trial being conducted?

This trial is being conducted at Marburg, Germany.

Who is sponsoring the NCT07323498 clinical trial?

NCT07323498 is sponsored by Philipps University Marburg. The principal investigator is Christoph Benke, Ph.D. at Philiips-University of Marburg. The trial plans to enroll 48 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology